Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study
Journal of Back and Musculoskeletal Rehabilitation · 2023
DOI: 10.3233/bmr-210319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Back and Musculoskeletal Rehabilitation, 2023. Verfasst von Lifeng Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Prosthesis-Related Infections, Arthroplasty, Replacement, Hip, Fractures, Bone. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Periprosthetic joint infection (PJI) is one of the worst complications following total joint arthroplasty (TJA). Unfortunately, effective prevention strategies to reduce the burden of PJI have not been fully determined in hip replacement patients with fracture and non-fracture. OBJECTIVE: This study aimed to analyze and compare the demographic characteristics, microbiological profiles and antibiotic resistance of PJI after hip replacement between patients with fracture and non-fracture. METHODS: We retrospectively analyzed the data of 132 patients who treated PJI. There were divided into two groups: non-fracture group (64 patients infected after hip replacement for fracture) and non-fracture group (68 patients infected after hip replacement for non-fracture). Microorganisms were obtained from the synovial fluid and infected necrotic tissue in the joint capsule, medullary cavity, or acetabulum in all patients, and microbiological profiles and antibiotic resistance were evaluated. RESULTS: Coagulase-negative staphylococci (CoNS) were the most common pathogenic microorganisms in all patients. Methicillin-resistant Staphylococcus (MRS) accounted for 25% in all pathogenic microbes. Staphylococci showed high drug resistance rates to clindamycin, levofloxacin, and all of the first- and second-generation cephalosporins. MRS isolates in non-fracture group had higher drug resistance rates to clindamycin and levofloxacin than than those in fracture group. Gram-negative bacilli (GNB) showed high drug resistance rates to Aztreonam, gentamicin and all of the third- and fourth-generation cephalosporins. Furthermore, GNB isolates in the non-fracture group showed higher resistance rates to gentamicin and all of the third- and fourth-generation cephalosporins. CONCLUSIONS: MRS isolates in the non-fracture group showed higher drug resistance rates to clindamycin and levofloxacin, and GNB isolates in non-fracture group showed higher drug resistance rates to gentamicin and all of the third- and fourth-generation cephalosporins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, China.
- Department of Orthopedics, The Fifth Central Hospital of Tianjin, Tianjin, China.
Zitieren
APA
Hu, L., Fu, J., Zhou, Y., Chai, W., Zhang, G., Hao, L., & Chen, J. (2023). Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study. Journal of Back and Musculoskeletal Rehabilitation. https://doi.org/10.3233/bmr-210319
Vancouver
Hu L, Fu J, Zhou Y, Chai W, Zhang G, Hao L, et al. Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study. Journal of Back and Musculoskeletal Rehabilitation. 2023. doi:10.3233/bmr-210319
BibTeX
@article{Hu2023,
author = {Hu, Lifeng and Fu, Jun and Zhou, Yonggang and Chai, Wei and Zhang, Guoqiang and Hao, Libo and Chen, Jiying},
title = {Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study},
journal = {Journal of Back and Musculoskeletal Rehabilitation},
year = {2023},
doi = {10.3233/bmr-210319}
}
EUVIMED